New delivery system for severe aortic stenosis treatment
Part of Heart & circulation clinical trials.
This trial tests a new delivery system (VitaFlow Liberty Flex) for placing a replacement aortic valve in people with severe aortic stenosis. It is designed for patients whose heart anatomy (a steep angle between the heart and aorta) makes the procedure more challenging.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have severe aortic stenosis (tight aortic valve) confirmed by heart ultrasound.
- The angle between your heart and aorta is steeper than 60 degrees, which may make standard valve delivery harder.
- You have symptoms that limit your daily activities, like shortness of breath or chest pain.
- You are willing and able to sign a consent form to participate.
- You do not have active infections, recent heart attack, severe other valve disease, or blood clotting problems.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows how the VitaFlow heart valve works in people age 70+ who have severe, narrowed aortic valves and cannot safely get open-heart valve surgery. It’s meant to see whether the device improves outcomes and is safe over time.
This trial tests a new valve replacement device (VitaFlow Liberty) that is inserted through a tube in an artery, avoiding open-heart surgery. It is for people with severe aortic stenosis who are at high risk for traditional surgery.
This trial is testing a new, less invasive way to replace a narrowed aortic valve using a special device. The goal is to help improve blood flow and reduce symptoms like chest pain and shortness of breath.
This study tests a new replacement valve for the aortic heart valve, delivered through a catheter (a thin tube) — a procedure called TAVR. It is for people who have severe aortic stenosis and are not good candidates for open-heart surgery.
This trial studies whether a new through-the-blood-vessel heart valve (TAVR) is safe and works well for people with severe aortic stenosis who are too risky for traditional surgery. If you qualify, you would be closely followed to check your symptoms and valve function over time.
This trial tests a minimally invasive procedure to replace a narrowed heart valve in emergency situations, such as cardiac arrest or severe heart failure. It aims to help people who are too sick for standard treatments and need immediate care.
Hear when a new Aortic Valve Stenosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.